Death & CV events among hospitalized COVID-19 patients | Casana raises $14M | 'Concerning' TAVR data

Even with numerous vaccines now being distributed, the COVID-19 pandemic continues to cause havoc for health systems all over the world. 

Casana, formerly known as Heart Health Intelligence, also named a new CEO. 

Researchers examined data from more than 98,000 patients who underwent transfemoral TAVR from January 2015 to March 2018. 

"Screening for CAS in adults without symptoms does more harm than good, and we continue to recommend against it," one USPSTF representative said. 

Two specialists have shared their own perspective on the updated ACC/AHA guidelines in Circulation.

The study, published in European Heart Journal, included decades of data from 20 different countries. 

Healthcare attorney Joel Porter talks with CVB about steps physicians can take to avoid signing on to a noncompete clause that will come back to haunt them.

The Louisville, Kentucky-based commercial insurer is teaming with home care provider DispatchHealth to make the offering happen.